CTOs on the Move


 
Kryo, Inc. is the world`s leading innovator of temperature-regulated and climate-control sleep solutions engineered to optimize health and wellness through enhanced quality sleep and patented technology. Kryo ranks no. 615 on the 2020 Inc. 5000 list.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.kryoinc.com
  • 144 Talbert Pointe Dr
    Mooresville, NC USA 28117
  • Phone: 704.235.6831

Executives

Name Title Contact Details

Funding

Kryo raised $20M on 12/23/2020

Similar Companies

AbbeyMoor Medical

AbbeyMoor Medical is a Parkers Prairie, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Shannondale

At Shannondale, we believe our residents` senior years should be stress-free and wonderful, so we offer a full continuum of care from short-term rehab to independent living to assisted or skilled nursing. We offer two locations in Knoxville and Maryville. Our community at Shannondale is strengthened by nurturing, compassionate, experienced staff who have innate passion for caring for others. We pride ourselves in a welcoming environment not only for residents, but for staff as well, with competitive benefits.

JK Associates

JK Associates is a Conshohocken, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cyclehaus

Our 50-minute Indoor Cycling class is a complete immersion into a high-intensity environment of energy and exercise. Our workouts are perfectly tailored to cutting edge playlists, and designed to be a retreat from everyday life. Each ride, physically and mentally stimulating, will challenge you to new heights.

Repertoire

Repertoire Immune Medicines is working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions, and infectious diseases. Repertoire scientists created and developed a suite of technologies for its DECODE discovery and DEPLOY product platforms that allow in-depth characterization of the immune synapse and the ability to rationally design, and clinically develop, multi-clonal immune medicines. The company is currently conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.